Basic Information
VerImmune aims to transform the lives of cancer patients by developing highly efficient immunotherapies. VerImmune is developing Antitumor Immune Redirection (AIR), a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.
VerImmune, Inc.
Washington,D.C.,United States of America
less than 15 people
January 01, 2020
JLABS@ Washington DC
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios